How did REVXF's recent EPS compare to expectations?
The most recent EPS for Revenio Group Oyj is $0.2, not beating expectations of $0.25.
How did Revenio Group Oyj REVXF's revenue perform in the last quarter?
Revenio Group Oyj revenue for the last quarter is $0.2
What is the revenue estimate for Revenio Group Oyj?
According to 7 of Wall street analyst, the revenue estimate of Revenio Group Oyj range from $29.4M to $26.46M
What's the earning quality score for Revenio Group Oyj?
Revenio Group Oyj has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Revenio Group Oyj report earnings?
Revenio Group Oyj next earnings report is expected in 2026-05-12
What are Revenio Group Oyj's expected earnings?
Revenio Group Oyj expected earnings is $33.04M, according to wall-street analysts.
Did Revenio Group Oyj beat earnings expectations?
Revenio Group Oyj recent earnings of $31.2M does not beat expectations.
Key Stats
Prev.Close
$25
Open
$25
Day's Range
$25 - $25
52 week range
$25 - $31.47
Volume
100
Avg.Volume
1
Dividend yield
--
EPS (TTM)
0.82
Market Cap
$667.0M
What is REVENIO GROUP OYJ?
Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 247 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.